Orchid Pharma Ltd reports Q2 FY27 standalone revenue of ₹341.27 crore, up 14% year on year
- EBITDA was ₹52 crore, with a 15% operating margin.
- Net profit rose 432% year on year to ₹36.76 crore; no exceptional items were reported.
- Presentation covered the completed amalgamation of Dhanuka Laboratories and business-development initiatives for EXBLIFEP.
